377 related articles for article (PubMed ID: 32973060)
1. Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis.
McLeod M; Sandiford P; Kvizhinadze G; Bartholomew K; Crengle S
BMJ Open; 2020 Sep; 10(9):e037145. PubMed ID: 32973060
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Jaine R; Kvizhinadze G; Nair N; Blakely T
Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer Screening: How Health Gains and Cost-Effectiveness Vary by Ethnic Group, the Impact on Health Inequalities, and the Optimal Age Range to Screen.
McLeod M; Kvizhinadze G; Boyd M; Barendregt J; Sarfati D; Wilson N; Blakely T
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1391-1400. PubMed ID: 28626068
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Jaine R; Kvizhinadze G; Nair N; Blakely T
Lung Cancer; 2020 Jun; 144():99-106. PubMed ID: 32317183
[TBL] [Abstract][Full Text] [Related]
5. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
6. Estimating the economic costs of Indigenous health inequities in New Zealand: a retrospective cohort analysis.
Reid P; Paine SJ; Te Ao B; Willing EJ; Wyeth E; Vaithianathan R; Loring B
BMJ Open; 2022 Oct; 12(10):e065430. PubMed ID: 36265912
[TBL] [Abstract][Full Text] [Related]
7. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Shirley R; Lawrenson R
BMC Public Health; 2015 Jan; 15():46. PubMed ID: 25637343
[TBL] [Abstract][Full Text] [Related]
8. The estimated health impact of alcohol interventions in New Zealand: A modelling study.
Chambers T; Mizdrak A; Herbert S; Davies A; Jones A
Addiction; 2024 Jan; 119(1):125-136. PubMed ID: 37649140
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of docetaxel versus weekly paclitaxel in adjuvant treatment of regional breast cancer in New Zealand.
Webber-Foster R; Kvizhinadze G; Rivalland G; Blakely T
Pharmacoeconomics; 2014 Jul; 32(7):707-24. PubMed ID: 24859241
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
[TBL] [Abstract][Full Text] [Related]
11. Health gains, costs and cost-effectiveness of a population-based screening programme for abdominal aortic aneurysms.
Nair N; Kvizhinadze G; Jones GT; Rush R; Khashram M; Roake J; Blakely A
Br J Surg; 2019 Jul; 106(8):1043-1054. PubMed ID: 31115915
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
Kowada A
BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
[TBL] [Abstract][Full Text] [Related]
13. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of lung MRI in lung cancer screening.
Allen BD; Schiebler ML; Sommer G; Kauczor HU; Biederer J; Kruser TJ; Carr JC; Hazen G
Eur Radiol; 2020 Mar; 30(3):1738-1746. PubMed ID: 31748855
[TBL] [Abstract][Full Text] [Related]
15. Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model.
Sun C; Zhang X; Guo S; Liu Y; Zhou L; Shi J; Wu N; Zhai Z; Liu G
BMJ Open; 2021 Jul; 11(7):e046742. PubMed ID: 34210726
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
[TBL] [Abstract][Full Text] [Related]
17. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
18. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Transport on Population Health and Health Equity for Māori in Aotearoa New Zealand: A Prospective Burden of Disease Study.
Randal E; Shaw C; McLeod M; Keall M; Woodward A; Mizdrak A
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206228
[TBL] [Abstract][Full Text] [Related]
20. Mortality trends in Australian Aboriginal peoples and New Zealand Māori.
Phillips B; Daniels J; Woodward A; Blakely T; Taylor R; Morrell S
Popul Health Metr; 2017; 15():25. PubMed ID: 28680369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
